230 related articles for article (PubMed ID: 28736635)
1. Immunotherapy in gastrointestinal cancers.
Grierson P; Lim KH; Amin M
J Gastrointest Oncol; 2017 Jun; 8(3):474-484. PubMed ID: 28736635
[TBL] [Abstract][Full Text] [Related]
2. The potential role of immunotherapy to treat colorectal cancer.
Amin M; Lockhart AC
Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
[TBL] [Abstract][Full Text] [Related]
3. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies.
Jesus VHF; Felismino TC; Barros E Silva MJ; Souza E Silva V; Riechelmann RP
Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e510s. PubMed ID: 30365605
[TBL] [Abstract][Full Text] [Related]
4. Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.
Bilgin B; Sendur MA; Bülent Akıncı M; Şener Dede D; Yalçın B
Curr Med Res Opin; 2017 Apr; 33(4):749-759. PubMed ID: 28055269
[TBL] [Abstract][Full Text] [Related]
5. Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality.
Kourie HR; Tabchi S; Ghosn M
World J Gastroenterol; 2017 May; 23(17):3017-3021. PubMed ID: 28533658
[TBL] [Abstract][Full Text] [Related]
6. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
Flickinger JC; Rappaport JA; Barton JR; Baybutt TR; Pattison AM; Snook AE; Waldman SA
Biomark Med; 2021 Feb; 15(3):201-217. PubMed ID: 33470843
[TBL] [Abstract][Full Text] [Related]
7. Developments in immunotherapy for gastrointestinal cancer.
Diaz JL; Wanta SM; Fishbein TM; Kroemer A
Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for GI Malignancies, Ready for Prime Time?
Tieniber AD; Perez JE; Hanna AN; DeMatteo RP
Ann Surg Oncol; 2023 Mar; 30(3):1787-1793. PubMed ID: 36273054
[TBL] [Abstract][Full Text] [Related]
9. Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy.
Hino C; Lee EW; Yang GY
J Gastrointest Oncol; 2023 Jun; 14(3):1613-1625. PubMed ID: 37435204
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers.
Saoudi González N; Castet F; Élez E; Macarulla T; Tabernero J
Front Oncol; 2022; 12():1021772. PubMed ID: 36300092
[TBL] [Abstract][Full Text] [Related]
11. Identification of genomic features associated with immunotherapy response in gastrointestinal cancers.
He Y; Liu ZX; Jiang ZH; Wang XS
World J Gastrointest Oncol; 2019 Apr; 11(4):270-280. PubMed ID: 31040893
[TBL] [Abstract][Full Text] [Related]
12. The role of microbiomes in gastrointestinal cancers: new insights.
Yarahmadi A; Afkhami H
Front Oncol; 2023; 13():1344328. PubMed ID: 38361500
[TBL] [Abstract][Full Text] [Related]
13. Current immunotherapy in gastrointestinal malignancies A Review.
Dahiya DS; Kichloo A; Singh J; Albosta M; Lekkala M
J Investig Med; 2021 Mar; 69(3):689-696. PubMed ID: 33443046
[TBL] [Abstract][Full Text] [Related]
14. Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers.
Peeters M; Cervantes A; Moreno Vera S; Taieb J
Future Oncol; 2018 Jul; 14(16):1629-1645. PubMed ID: 29701076
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal cancers in India: Treatment perspective.
Ghadyalpatil NS; Supriya C; Prachi P; Ashwin D; Avanish S
South Asian J Cancer; 2016; 5(3):126-36. PubMed ID: 27606298
[TBL] [Abstract][Full Text] [Related]
16. Aquaporins: Their role in gastrointestinal malignancies.
Nagaraju GP; Basha R; Rajitha B; Alese OB; Alam A; Pattnaik S; El-Rayes B
Cancer Lett; 2016 Apr; 373(1):12-18. PubMed ID: 26780474
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects.
Zhou C; Zhang J
Front Med; 2019 Feb; 13(1):12-23. PubMed ID: 30796606
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in Gastrointestinal Malignancies.
Mizrahi J; Pant S
Adv Exp Med Biol; 2020; 1244():93-106. PubMed ID: 32301012
[TBL] [Abstract][Full Text] [Related]
19. A topography of immunotherapies against gastrointestinal malignancies.
Dhasmana A; Dhasmana S; Kotnala S; Anukriti A; Kashyap VK; Shaji PD; Laskar P; Khan S; Pellicano R; Fagoonee S; Haque S; Yallapu MM; Chauhan SC; Jaggi M
Panminerva Med; 2022 Mar; 64(1):56-71. PubMed ID: 34664484
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal tumor board: an evolving experience in Tehran Cancer Institute.
Haddad P; Mir MR; Jamali M; Abdirad A; Alikhasi A; Farhan F; Memari F; Sadighi S; Shahi F
Acta Med Iran; 2013 May; 51(4):270-3. PubMed ID: 23690109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
